Top compounds associated with response to MYBL2


Feature Type Standardized
Nominal ANOVA
mRNA MLN4924 CTRPv2 pan-cancer AAC 0.022 0.5
mRNA FR-180204 GDSC1000 pan-cancer AAC -0.022 0.5
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.021 0.5
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.023 0.6
mRNA TPCA-1 GDSC1000 pan-cancer AAC 0.018 0.6
mRNA MG-132 GDSC1000 pan-cancer AAC 0.032 0.6
mRNA Sunitinib FIMM pan-cancer AAC -0.12 0.6
mRNA AT13387 CTRPv2 pan-cancer AAC 0.029 0.6
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.021 0.6
mRNA AICAR GDSC1000 pan-cancer AAC 0.02 0.6
Download CSV